Envoy Medical COCH Debt Instrument Convertible Conversion Price
Debt Instrument Convertible Conversion Price at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockConvertibleConversionPrice.
The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's debt instrument convertible conversion price.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's debt instrument convertible conversion price?
- Envoy Medical (COCH) reported debt instrument convertible conversion price of $11.50 in Q1 2026.
- How has Envoy Medical's debt instrument convertible conversion price changed year-over-year?
- Envoy Medical's debt instrument convertible conversion price decreased by 0.0% year-over-year, from $11.50 to $11.50.
- What is the long-term trend for Envoy Medical's debt instrument convertible conversion price?
- Over 2 years (2023 to 2025), Envoy Medical's debt instrument convertible conversion price has grown at a 0.0% compound annual growth rate (CAGR), from $11.50 to $11.50.
- What does debt instrument convertible conversion price mean?
- The predetermined price at which a holder of a convertible debt instrument can exchange their debt for equity shares. This metric is critical for evaluating potential shareholder dilution and the attractiveness of the debt instrument to investors.